Anavex Life Sciences
AVXL
#7501
Rank
NZ$0.69 B
Marketcap
NZ$7.80
Share price
-4.28%
Change (1 day)
-54.04%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.93

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.90. a decrease over its 2024 EPS that were of NZ-$0.86.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.903.85%
2024NZ-$0.86-13.33%
2023NZ-$1.00-3.23%
2022NZ-$1.0314.81%
2021NZ-$0.9020%
2020NZ-$0.75-16.67%
2019NZ-$0.9038.46%
2018NZ-$0.6518.18%
2017NZ-$0.55-21.43%
2016NZ-$0.70-35.38%
2015NZ-$1.08-36.27%
2014NZ-$1.69112.5%
2013NZ-$0.80-58.62%
2012NZ-$1.93-0%
2011NZ-$1.93-29.27%
2010NZ-$2.7251.85%
2009NZ-$1.79-0%
2008NZ-$1.79237.5%
2007NZ-$0.53
2006N/A-100%
2005NZ-$0.06642499.97%
2004NZ-$0.01107

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$3.97-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.66-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$49.65 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08302-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA